Kayne Anderson Rudnick Investment Management LLC boosted its stake in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 1.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 233,318 shares of the medical device company’s stock after purchasing an additional 2,270 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned approximately 0.48% of Cooper Companies, Inc. (The) worth $55,322,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its stake in Cooper Companies, Inc. (The) by 3.3% during the 2nd quarter. Vanguard Group Inc. now owns 4,938,181 shares of the medical device company’s stock valued at $1,182,298,000 after acquiring an additional 156,449 shares in the last quarter. BlackRock Inc. raised its stake in Cooper Companies, Inc. (The) by 4.5% during the 2nd quarter. BlackRock Inc. now owns 3,210,032 shares of the medical device company’s stock valued at $768,546,000 after acquiring an additional 138,395 shares in the last quarter. Janus Henderson Group PLC raised its stake in Cooper Companies, Inc. (The) by 558.5% during the 2nd quarter. Janus Henderson Group PLC now owns 2,175,791 shares of the medical device company’s stock valued at $520,937,000 after acquiring an additional 1,845,368 shares in the last quarter. Pioneer Investment Management Inc. raised its stake in Cooper Companies, Inc. (The) by 136.6% during the 2nd quarter. Pioneer Investment Management Inc. now owns 1,226,250 shares of the medical device company’s stock valued at $293,589,000 after acquiring an additional 708,028 shares in the last quarter. Finally, Bessemer Group Inc. raised its stake in Cooper Companies, Inc. (The) by 39.1% during the 2nd quarter. Bessemer Group Inc. now owns 575,951 shares of the medical device company’s stock valued at $137,895,000 after acquiring an additional 161,772 shares in the last quarter. Institutional investors and hedge funds own 96.71% of the company’s stock.

Shares of Cooper Companies, Inc. (NYSE:COO) traded down $2.12 during trading on Thursday, hitting $234.66. The stock had a trading volume of 343,700 shares, compared to its average volume of 427,354. The firm has a market capitalization of $11,590.20, a price-to-earnings ratio of 25.32, a PEG ratio of 2.03 and a beta of 0.55. The company has a quick ratio of 1.29, a current ratio of 2.51 and a debt-to-equity ratio of 0.38. Cooper Companies, Inc. has a 12 month low of $158.73 and a 12 month high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its earnings results on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.58 by $0.06. The company had revenue of $556.00 million for the quarter, compared to analyst estimates of $552.32 million. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. Cooper Companies, Inc. (The)’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.30 earnings per share. equities analysts anticipate that Cooper Companies, Inc. will post 9.72 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/16/kayne-anderson-rudnick-investment-management-llc-has-55-32-million-position-in-cooper-companies-inc-the-coo.html.

In other news, Director Gary S. Petersmeyer sold 3,977 shares of the business’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.60% of the stock is owned by insiders.

Several analysts have weighed in on the company. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies, Inc. (The) in a research note on Friday, July 21st. Stifel Nicolaus lifted their target price on Cooper Companies, Inc. (The) from $265.00 to $275.00 and gave the company a “buy” rating in a research note on Tuesday, September 12th. J P Morgan Chase & Co reissued a “hold” rating and issued a $235.00 price objective on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Robert W. Baird reissued a “buy” rating and issued a $273.00 price objective (up previously from $267.00) on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Finally, Oppenheimer Holdings, Inc. reissued a “hold” rating and issued a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Cooper Companies, Inc. (The) has a consensus rating of “Buy” and a consensus target price of $260.22.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.